RxDoctor Payments Data

Vikas Mehta, MD

Otolaryngology · Shreveport, LANPI 1902097108

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $6,600 of the $8,339 with a category attached, or 79.1%. 11 manufacturers reported payments, led by Merck at 48.0% of the total. 2025 is the largest year on record at $2,726, more than ten times the $123 reported in 2019. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$8,339in general payments, 2019–2025

Across 16 payments — averaging $521.20 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$4K
  • Janssen Global Services, LLC$3K
  • Pfizer$1K
  • Johnson & Johnson$145
  • Med-el Corporation$115
  • AstraZeneca$107
  • plus $122 from 5 others

What the payments were for

  • Consulting fees$6,60079%
  • Speaking & faculty fees$1,25015%
  • Food & beverage$4896%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,339 in reported general payments places this provider in the 90th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana

Medicare billing

Part B allowed, 2024
$50,172
Medicare patients
86
Services billed
225

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate16$1,142
Levothyroxine Sodium64$499
Calcitriol12$147
Oxycodone Hcl16$36

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Shreveport

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →